
## **Trustees’ Annual Report for the period** 

**From 6[th] October 2023 To 4[th] October 2024 Charity name: Kernow Kidney Patient Association** 

## **Charity registration number:1205096** 

## **Objectives and Activities** 

|**Objectives and Activities**|||
|---|---|---|
||SORP reference||
|Summary of the purposes of the<br>charity as set out in its governing<br>document|Para 1.17|This charity has been formed by kidney patents in<br>Cornwall for the beneft of kidney patents and their<br>carers in Cornwall. The charity objectves are:<br>(A)<br>THE RELIEF OF SICKNESS AND DISTRESS<br>AMONG KIDNEY PATIENTS AND THEIR<br>CARERS OR FAMILIES ACROSS<br>CORNWALL BY THE PROVISION OF<br>SUPPORT, ADVICE AND INFORMATION<br>IN SUCH WAYS AS THE TRUSTEES SEE<br>FIT<br>(B)<br>THE ADVANCEMENT OF THE<br>EDUCATION OF THE PUBLIC<br>CONCERNING KIDNEY DISEASES AND<br>THEIR TREATMENTS,  INCLUDING THE<br>IMPORTANCE OF ORGAN DONATION.|
|Summary of the main actvites in<br>relaton to those purposes for the<br>public beneft, in partcular, the<br>actvites, projects or services<br>identfed in the accounts.|Para 1.17 and<br>1.19|In order to develop this new charity and to<br>contribute to the objectves we set out above, the<br>trustees have worked hard this year to establish the<br>charity and to positon it so that it is ready to start its<br>second year of operaton.<br>Key actvites have focused on startng the new<br>charity, developing the policies and procedures that<br>underpin the charity and in developing our inital<br>contacts with the hospital and with local patents.<br>In additon, fundraising actvites have started in<br>order to fnance our set up and running costs and to<br>be able to begin some small grant making in order to<br>improve support for renal patents on dialysis.<br>We have also started to raise awareness of kidney<br>disease in the wider community.|
|Statement confrming whether<br>the trustees have had regard to<br>the guidance issued by the<br>CharityCommission onpublic|Para 1.18|As trustees we can confrm that we have at all tmes<br>tried to follow the public beneft guidance as<br>outlined by the Charity Commission. This was<br>reiterated at our last Trustee meetngon October|





4[th] . 

benefit 

## Additonal informaton 

: 

|Additonal informaton<br>:|||
|---|---|---|
||SORP reference||
|Policy on grant making|Para 1.38|Trustees have agreed a policy on grantng funding.<br>Funding is conditonal on:<br><br>Meetng the objectves of the charity<br><br>Ensuring there is sufcient funding held in<br>the charity to cover essental costs such as<br>insurance, venue costs for meetngs and<br>general administraton of the charity.<br><br>No stafare employed by the charity and<br>there are no capital costs.<br>Grants are made with Trustee approval and the<br>policy for grant making is reviewed on an<br>annual basis.|
|Contributon made by volunteers|Para 1.38|Trustees acknowledge that the charity could not run<br>without the help and support of volunteers. They<br>would like to thank everyone who has helped<br>throughout the year.|
|Other||Trustees have been very grateful throughout this<br>period for the help and support they have received<br>from the renal team and Voluntary Services at<br>Treliske hospital and from patent volunteers who<br>are already engaging with the charity.<br>All trustees involved this year have also worked<br>extremely hard, despite being patents or carers<br>themselves. As a group trustees are thankful for<br>everyone involved- including two external<br>organisatons, the Natonal Kidney Federaton and<br>Kidney Care UK who have both helped with ongoing<br>support and advice.|



## Achievements and Performance 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identfying the diference the<br>charity’s work has made to the<br>circumstances of its benefciaries<br>and any wider benefts to society<br>as a whole.|Para 1.20|Key actvites and achievements have included:<br><br>Ensuring the charity has been set up to be<br>efectve, with a model of ongoing policy<br>review and development, appropriate<br>banking systems and fnancial reportng<br>and a focus on compliance with, for<br>example, safeguarding, health and<br>safety.data protecton and equality and<br>diversity. Trustee meetngs have been held<br>regularly with agreed minutes and a<br>strategic plan in place in order to drive<br>forward the work of the charity. We<br>believe the charity to be on a sound footng<br>to enter its second year of operaton.<br><br>The charity has developed partnership<br>working with the renal team and are<br>beginning to hold joint meetngs for<br>patents and carers that focus on improving<br>outcomes for patents and on ofering<br>support forpatents and carers. The charity|





started with a small group of 15 people but throughout the year numbers have steadily increased. The charity now has a mailing list of over 50 patents and carers and numbers atending meetngs are increasing.  The charity is developing its profle within the community and has been able to advance knowledge of kidney disease within the wider public by, for example, atending informaton sessions at a local conference and charity awareness raising day, having stalls in public places such as the foyer in supermarkets and through atending popular local events such as local countryside shows.  Fundraising has been supported at these events and in partcular the charity has been fortunate to receive support from a local Male Voice Choir, Rotary Club and dance academy- all have organised events for the charity or sponsored the charity. This has enabled us to fundraise to pay for our central costs such as venue hire and insurances and allows us to start making donatons to improve the patent experience at the local hospital. We will retain some contngency for the year 202425 in order that we know the public liability insurances are covered and we are able to run our meetngs. 

Additonal informaton (optonal) You may choose to include further statements where relevant about: 

|Performance of fundraising<br>actvites against objectves set|Para 1.41|There was an inital delay to fundraising in order<br>that a bank account could be established. This was<br>eventually operatonal by February 2024.<br>In the last few months we have exceeded our inital<br>goal which was to be fnancially viable and have<br>been able to make a donaton to the renal ward at<br>Treliske hospital for some cushions for patent<br>comfort. We are now in the process of reviewing a<br>request for support for other equipment for patent<br>use whilst theyreceive dialysis.|
|---|---|---|
|Other|||





Financial Review 

|Review of the charity’s fnancial<br>positon at the end of theperiod|Para 1.21||
|---|---|---|
|Statement explaining the policy<br>for holding reserves statng why<br>they are held|Para 1.22|It has been agreed that at present reserves of £250<br>are held in order to fnance the insurance costs for<br>2024-25. This leaves very litle but we are aware<br>that as a new charityfunds are stll limited.|
|Amount of reserves held|Para 1.22||
|Reasons for holdingzero reserves|Para 1.22||
|Details of fund materiallyin defcit|Para 1.24||
|Explanaton of any uncertaintes<br>about the charity contnuing as a<br>going concern|Para 1.23|We believe the charity should be in a strong<br>positon to enter its second year. However, the<br>charity will require ongoing volunteers, partcularly<br>those willing to be trustees, in order to be<br>sustainable in the future.|





Structure, Governance and Management 

|Descripton of charity’s trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed,royal charter)|Para 1.25|The charity has a consttuton based on the Charity<br>Commission template 2023.|
|How is the charity consttuted?<br>(e.g unincorporated associaton,<br>CIO)|Para 1.25|The charity has been established as a Charitable<br>Incorporated Organisaton|
|Trustee selecton methods<br>including details of any<br>consttutonal provisions e.g.<br>electon to post or name of any<br>person or body enttled to<br>appoint one or more trustees|Para 1.25|Trustees may be appointed following electon at the<br>Annual General Meetng or a properly consttuted<br>meetng of Trustees.|



## Additonal informaton (optonal) 

You may choose to include further statements where relevant about: 

|Policies and procedures adopted<br>for the inducton and training of<br>trustees|Para 1.51|New Trustees receive an informaton pack with<br>policies and procedures and the consttuton. In<br>additon, due to the fact trustees may be visitng the<br>hospital and may be face to face with patents, it<br>has been agreed that Trustees will also register with<br>the hospital Voluntary Service team, this includes<br>receiving their DBS check and inducton training<br>with the hospital.|
|---|---|---|
|The charity’s organisatonal<br>structure and any wider network<br>with which the charity works|Para 1.51|The charity is very pleased to have been accepted as<br>an afliate organisaton of the Natonal Kidney<br>Federaton. This enttles the charity to be involved<br>at a natonal level with this specialist organisaton.<br>We also receive advice and guidance from Kidney<br>Care UK.|
|Relatonship with any related<br>partes|Para 1.51|Two trustees are related. Both are aware of any<br>confict of interest and this would be declared at<br>meetngs.|
|Other|||



## Reference and Administratve details 

|Charityname|Kernow KidneyPatent Associaton|
|---|---|
|Other name the charityuses|-|
|Registered charitynumber|1205096|
|Charity’s principal address|Hill Crest<br>Coverack Bridges<br>Helston<br>Cornwall<br>TR13 0LX|
|||





## Names of the charity trustees who manage the charity 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|Trustee name|Ofce (if any)|Dates acted if not for whole<br>year|Name of person (or body) enttled<br>to appoint trustee(if any)|
|---|---|---|---|---|
||Mike Savage|Chair|March 2024|Trustees|
||Sharon Clarke|Treasurer|October 2023||
||Sophia Clarke|Social Media|October 2023||
||Karen Richardson|Assistant Secretary|October 2023||
||Carol Kimberley|Secretary|October 2023||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



Corporate trustees – names of the directors at the date the report was approved Director name N/A 

Name of trustees holding title to property belonging to the charity 

|Trustee name|Dates acted if not for wholeyear||
|---|---|---|
|N/A|||
||||
||||
||||
||||
||||





Funds held as custodian trustees on behalf of others Description of the assets held in N/A this capacity Name and objects of the charity N/A on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for safe N/A custody and segregation of such assets from the charity’s own assets 

## Additonal informaton (optonal) 

Names and addresses of advisers (Optonal informaton) 

|Type of<br>adviser|Name<br>Address|Name<br>Address|
|---|---|---|
|N/A|||
||||
||||
||||



Name of chief executve or names of senior staf members (Optonal informaton) 

N/A 

## Exemptons from disclosure 

Reason for non-disclosure of key personnel details 

N/A 

Other optonal informaton N/A 



Declaratons 

The trustees declare that they have approved the trustees’ report above. 

Signed on behalf of the charity’s trustees 

Signature(s) Full name(s) on (eg Secretary, Chair, etc) Date 



||**Kernow Kidney Patient**<br>**Associationarity Name**|**Kernow Kidney Patient**<br>**Associationarity Name**|**Kernow Kidney Patient**<br>**Associationarity Name**|**Kernow Kidney Patient**<br>**Associationarity Name**|**Kernow Kidney Patient**<br>**Associationarity Name**|**1205096**|**1205096**||**CC16a**|
|---|---|---|---|---|---|---|---|---|---|
|||||||||||
||**Receipts and payments accounts**|||||||||
||**For the**<br>**period from**||1.10.23||**To**|30.9.24||||
|||||||||||
|||||||||||
|**Section A Receipts and payments**||||||||||
||**Unrestric**<br>**ted funds**||**Restricte**<br>**d funds**||**Endowm**<br>**ent**<br>**funds**||**Total**<br>**funds**||**Last**<br>**year**|
||**to the**<br>**nearest**<br>**£**||**to the**<br>**nearest £**||**to the**<br>**nearest**<br>**£**||**to the**<br>**nearest**<br>**£**||**to the**<br>**nearest**<br>**£**|
|**A1 Receipts**||||||||||
|Memorial and<br>donations|**1,088**||**-**||**-**||**1,088**||**-**|
|Other activities|**1,738**||**-**||**-**||**1,738**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_**_(Gross_<br>_income for AR)_|**2,826**||**-**||**-**||**2,826**||**-**|
|||||||||||
|**A2 Asset and**<br>**investment sales,**<br>**(see table). **||||||||||
||**-**||**-**||**-**||**-**|||
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_**|**-**||**-**||**-**||**-**||**-**|
|||||||||||
|**_Total receipts_**|**2,826**||**-**||**-**||**2,826**||**-**|
|||||||||||
|**A3 Payments**||||||||||





|Patient support<br>meetings|**124**||**-**||**-**||**124**||**-**|
|---|---|---|---|---|---|---|---|---|---|
|Renal unit equipment|**160**||**-**||**-**||**160**||**-**|
|Expense payment for<br>insurance|**153**||**-**||**-**||**153**||**-**|
|admin costs and<br>regulatory|**188**||**-**||**-**||**188**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_**|**625**||**-**||**-**||**625**||**-**|
|||||||||||
|**A4 Asset and**<br>**investment**<br>**purchases, (see**<br>**table)**||||||||||
||**-**||**-**||**-**||**-**|||
||**-**||**-**||**-**||**-**|||
|**_Sub total_**|**-**||**-**||**-**||**-**||**-**|
|||||||||||
|**_Total payments_**|**625**||**-**||**-**||**625**||**-**|
|||||||||||
|**_Net of_**<br>**_receipts/(payments)_**|**2,201**||**-**||**-**||**2,201**||**-**|
|**A5 Transfers between**<br>**funds**|**-**||**-**||**-**||**-**||**-**|
|**A6 Cash funds last**<br>**year end**|**-**||**-**||**-**||**-**||**-**|
|**_Cash funds this year_**<br>**_end_**|**2,201**||**-**||**-**||**2,201**||**-**|
|||||||||||
|||||||||||
|**Section B Statement of assets and liabilities at the end of the period**||||||||||
|**Categories**|**Details**||||**Unrestri**<br>**cted**<br>**funds**||**Restrict**<br>**ed funds**||**Endow**<br>**ment**<br>**funds**|





||||**to**<br>**nearest**<br>**£**||**to**<br>**nearest**<br>**£**||**to**<br>**nearest**<br>**£**|
|---|---|---|---|---|---|---|---|
|**B1 Cash funds**|||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||**_Total cash funds_**||**2,201**||**-**||**-**|
||(agree balances with<br>receipts and payments<br>account(s))||OK||OK||OK|
||||**Unrestri**<br>**cted**<br>**funds**||**Restrict**<br>**ed funds**||**Endow**<br>**ment**<br>**funds**|
||**Details**||**to**<br>**nearest**<br>**£**||**to**<br>**nearest**<br>**£**||**to**<br>**nearest**<br>**£**|
|**B2 Other monetary**<br>**assets**|||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
|||||||||
||**Details**||**Fund to**<br>**which**<br>**asset**<br>**belongs **||**Cost**<br>**(optional**<br>**)**||**Current**<br>**value**<br>**(optiona**<br>**l)**|
|**B3 Investment assets**|||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
|||||||||
||**Details**||**Fund to**<br>**which**||**Cost**<br>**(optional**<br>**)**||**Current**<br>**value**|





|||||||**asset**<br>**belongs **||||**(optiona**<br>**l)**|
|---|---|---|---|---|---|---|---|---|---|---|
|**B4 Assets retained**<br>**for the charity’s own**<br>**use**||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
||||||||||||
|||**Details**||||**Fund to**<br>**which**<br>**liability**<br>**relates**||**Amount**<br>**due**<br>**(optional**<br>**)**||**When**<br>**due**<br>**(optiona**<br>**l)**|
|**B5 Liabilities**||||||||**-**|||
|||||||||**-**|||
|||||||||**-**|||
|||||||||**-**|||
|||||||||**-**|||
||||||||||||
|Signed by one or two<br>trustees on behalf of<br>all the trustees||Signature||||Print Name||||Date of<br>approval|
|||||||c a kimberley||||1.11.24|
||||||||||||



